- Director of LentiCure B.V., a 100% subsidiary of Erasmus MC.
- Director and founder of Ventinova Medical. Between 2013 and 2022 he led Ventinova Medical, a company that develops medical ventilation products. Under his leadership, the company grew and became active in more than 20 countries.
- Director and founder of Dolphys Medical. A company that develops medical implants and ventilation systems. He later passed on the ventilation activities of this company to Ventinova Medical. More information on Linked-In
"We are in a hurry. People with a rare muscle disease or brain disease are deteriorating every day. And the treatment costs continue to rise. Together we have to change the healthcare market for these types of diseases."
About Dirk van Asseldonk
Dirk is known for his ability to bring science and business together and his ability to find new paths for corporate financing. He has a clear vision of what he wants to achieve and works practically, but also empathetically. He always looks for solutions to business challenges, in which he attaches great importance to quality, safety and sustainability.
"For rare diseases, the current healthcare market needs a different approach, otherwise medicines will become too expensive and unattainable. LentiCure is committed to transparent, socially responsible prices. If we make more profit in the future than is necessary to guarantee continuity, then I have not done my job properly. Then we have sold the products at too high a price. At LentiCure, no one has shares, options or a profit distribution."